Kyntra Bio, Inc. (KYNB) Financials
KYNB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 109.6 million | 118.9 million |
| Dec. 31, 2025 | 119.6 million | 115.1 million |
| Sept. 30, 2025 | 137.0 million | 119.5 million |
| June 30, 2025 | 178.1 million | 359.1 million |
KYNB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -13.9 million | 1.2 million |
| Dec. 31, 2025 | -18.3 million | 1.2 million |
| Sept. 30, 2025 | -1.9 million | ? |
| June 30, 2025 | 12.7 million | 1.9 million |
KYNB Net Income
No data available :(
KYNB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 87.2 million | - | - |
| Dec. 31, 2025 | 89.0 million | - | - |
| Sept. 30, 2025 | 118.0 million | 19.5 million | - |
| June 30, 2025 | 23.4 million | - | - |
KYNB Shares Outstanding
KYNB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 7.6 million | 5.9 million | - |
| Dec. 31, 2025 | - | 7.3 million | 7.3 million | - |
| Sept. 30, 2025 | 8999 | 1.2 million | 5.1 million | - |
| June 30, 2025 | 13000 | 5.9 million | 6.8 million | - |
KYNB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 3.7 million | - |
| Dec. 31, 2025 | 1.3 million | - |
| Sept. 30, 2025 | 1.1 million | 134000 |
| June 30, 2025 | 1.3 million | 306000 |
KYNB Revenue by Segment
Graph available only for paid members. Upgrade to see it.
KYNB
Price: $6.68
52 week price:
Earnings Per Share: -12.85 USD
P/E Ratio: -0.54
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 29.1 million